Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area

Clinical trial NCT05266729 · COMPLETED

Trial details

NCT number: NCT05266729
Sponsor: AMIpharm Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate or Severe Submental Fullness

Start date: 2022-03-02
Primary completion: 2022-12-28
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.